BLOGS
What is the Main Role of Tau Protein in Neurons?

It is encoded by the MAPT gene and is primarily expressed in neurons
Tau protein's main function is to stabilize and promote the assembly of microtubules, which are part of the cytoskeleton and provide structure and shape to cells
They also enable the transport of organelles, vesicles, and proteins along their length
This transport is essential for the proper functioning of neurons, including the transmission of signals and the delivery of molecules and organelles to the axon terminal for neurotransmission.
Structure and Function of Tau Protein
The binding of tau to microtubules promotes their polymerization and inhibits their depolymerization, thereby stabilizing the microtubule structure
Tau also interacts with other microtubule-associated proteins and molecular motors, regulating their activity and the transport of cargo along microtubules
This regulation is important for the proper distribution of organelles and proteins in neurons and for the maintenance of neuronal polarity.
Role of Tau in Neurodegenerative Diseases
It can be phosphorylated by various kinases, which regulates its activity and interactions
Hyperphosphorylated tau can detach from microtubules, leading to microtubule destabilization and the formation of insoluble tau aggregates
These aggregates are a hallmark of several neurodegenerative diseases, including Alzheimer's disease, frontotemporal dementia, and progressive supranuclear palsy, among others
The deposition of tau pathology follows a specific spatial and temporal pattern in the brain, with different brain regions being affected at various stages of disease
This pattern of deposition correlates with the progression of clinical symptoms in patients with tauopathies.
Propagation of Tau Pathology
This process is thought to contribute to the progression of tau pathology in the brain
Tau aggregates can also be released into the extracellular space, where they can be taken up by other neurons, promoting the spread of pathology
This interneuronal transmission of tau aggregates may underlie the progression of tau pathology in the brains of patients with tauopathies.
Therapeutic Strategies Targeting Tau
These include active and passive immunotherapies, which aim to clear tau aggregates from the brain, and small molecule inhibitors of tau aggregation and phosphorylation
Tau-directed therapies are currently being tested in clinical trials for the treatment of Alzheimer's disease and other tauopathies
These therapies hold promise for slowing or halting the progression of tau pathology in the brain and for improving the clinical symptoms of patients with tauopathies.
Conclusion
Its hyperphosphorylation and aggregation are central to the pathogenesis of several neurodegenerative diseases
Further research is needed to fully understand the mechanisms of tau pathology and to develop effective therapeutic strategies for the treatment of tauopathies
Elucidating the structural and functional properties of tau protein and the molecular mechanisms of tau pathology will be crucial for the development of novel therapies for these devastating diseases.
Featured MAPT proteins at Creative BioMart include: Recombinant Human MAPT, His-tagged